3 Factor Indexing’s Eli Lilly LLY Stock Holding History

3 Factor Indexing’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$686K	Hold	572	–	–	0.58%	28
2026 Q1	$526K	Buy	+572	New	+$580K	0.5%	32

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

3 Factor Indexing's LLY Position: Q2 2026 in Review

3 Factor Indexing held its Eli Lilly (LLY) position steady in Q2 2026 at 572 shares worth $686K. The position accounts for 0.58% of the portfolio, ranked #28.

3 Factor Indexing first reported a position in LLY in Q1 2026 and has held it in 2 quarters since. 4,431 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

3 Factor Indexing held 572 shares of Eli Lilly worth $686K as of Q2 2026.
3 Factor Indexing left its Eli Lilly share count unchanged in Q2 2026.
Eli Lilly made up 0.58% of 3 Factor Indexing's portfolio in Q2 2026, its #28 holding.
3 Factor Indexing first reported a position in Eli Lilly in Q1 2026 and has held it in 2 quarters since.
4,431 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on 3 Factor Indexing's 13F filing for Q2 2026, filed 8 Jul 2026.